SUGANO TEPPEI

Research field (1)： Other

Research theme for competitive and other funds (1)：

2018 - 2022 Researching for mechanism of acquired resistance in lung cancer

Papers (86)：

Kakeru Hisakane, Masahiro Seike, Teppei Sugano, Kuniko Matsuda, Takeru Kashiwada, Shinji Nakamichi, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Kaoru Kubota, et al. Title: Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer. Gene. 2023. 857. 147177-147177
Akiko Takahashi, Rintaro Noro, Natsuki Takano, Kakeru Hisakane, Satoshi Takahashi, Aya Fukuizumi, Miwako Omori, Teppei Sugano, Susumu Takeuchi, Shinji Nakamichi, et al. Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma. Molecular and clinical oncology. 2022. 16. 4. 87-87
Natsuki Takano, Masahiro Seike, Teppei Sugano, Kuniko Matsuda, Kakeru Hisakane, Akiko Yoshikawa, Shinji Nakamichi, Rintaro Noro, Akihiko Gemma. A Novel Molecular Target in EGFR-mutant Lung Cancer Treated With the Combination of Osimertinib and Pemetrexed. Anticancer research. 2022. 42. 2. 709-722
Ken Okamura, Rintaro Noro, Kazue Fujita, Shoko Kure, Shinobu Kunugi, Hitoshi Takano, Ryota Miyashita, Takehiro Tozuka, Toru Tanaka, Teppei Sugano, et al. Acute respiratory failure due to Aspergillus niger infection with acute fibrinous and organazing pneumonia: A case report. Respiratory medicine case reports. 2022. 37. 101641-101641
久金翔, 清家正博, 菅野哲平, 吉川明子, 松田久仁子, 高野夏希, 高橋聡, 野呂林太郎, 弦間昭彦. エクソソーム由来のmiR-210はEGFR変異陽性NSCLCにおけるオシメルチニブ耐性に関与する. 日本癌治療学会学術集会抄録集. 2021. 59回. P24-2

ｍore...

MISC (118)：

高野夏希, 清家正博, 大森美和子, 福泉彩, 久金翔, 中道真仁, 菅野哲平, 松本優, 宮永晃彦, 久保田馨, et al. Combination of Osimertinib and Pemetrexed Enhanced Apoptosis and Delayed the Acquired Drug Resistance in NSCLC with EGFR Mutations. 日本呼吸器学会誌(Web). 2021. 10
山田麻以, 帆足俊彦, 森田孝, 船坂陽子, 佐伯秀久, 菅野哲平, 清家正博, 弦間昭彦, 寺崎泰弘. 肺原発と考えられた悪性黒色腫の1例. 日本皮膚科学会雑誌. 2021. 131. 1
久金翔, 菅野哲平, 高野夏希, 大森美和子, 福泉彩, 高橋聡, 恩田直美, 中道真仁, 松本優, 峯岸裕司, et al. miR-125a-3p level in serum exosomes predicts therapeutic effect of ICI in NSCLC. 日本呼吸器学会誌(Web). 2021. 10
松木覚, 中道真仁, 清水理光, 恩田直美, 菅野哲平, 峯岸裕司, 野呂林太郎, 久保田馨, 清家正博, 弦間昭彦. Cross resistance to nab-paclitaxel and other taxanes in non-small cell lung cancer. 日本呼吸器学会誌(Web). 2021. 10
大森美和子, 野呂林太郎, 松田久仁子, 平尾真季子, 清水理光, 高野夏希, 福泉彩, 久金翔, 恩田直美, 高橋聡, et al. The inhibitors of ABC transporters overcome the resistance of the topoisomerase inhibitors in small cell lung cancer. 日本呼吸器学会誌(Web). 2021. 10

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page